Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$927K Sell
2,831
-5,198
-65% -$1.65M 0.87% 26
2025
Q3
$2.27M Sell
8,029
-214
-3% -$62.1K 0.84% 28
2025
Q2
$2.3M Buy
8,243
+206
+3% +$58.4K 0.91% 25
2025
Q1
$2.5M Sell
8,037
-14
-0.2% -$4.13K 1.2% 21
2024
Q4
$2.1M Buy
8,051
+216
+3% +$64.1K 0.94% 25
2024
Q3
$2.52M Sell
7,835
-716
-8% -$234K 1.15% 21
2024
Q2
$2.67M Sell
8,551
-417
-5% -$123K 1.13% 22
2024
Q1
$2.55M Sell
8,968
-67
-0.7% -$19.6K 1.11% 24
2023
Q4
$2.6M Buy
9,035
+292
+3% +$79.6K 1.22% 22
2023
Q3
$2.35M Buy
8,743
+5,395
+161% +$1.35M 1.25% 19
2023
Q2
$743K Sell
3,348
-2,883
-46% -$669K 0.8% 25
2023
Q1
$1.51M Buy
6,231
+2,676
+75% +$657K 1.02% 21
2022
Q4
$934K Buy
+3,555
New +$953K 1.34% 18

Other funds holding AMGN

STF Management's AMGN Position: Q4 2025 in Review

STF Management reduced its Amgen (AMGN) stake by 65% in Q4 2025, selling an estimated $1.65M and leaving 2,831 shares worth $927K. The position accounts for 0.87% of the portfolio, ranked #26.

STF Management first reported a position in AMGN in Q4 2022 and has held it in 13 quarters since. The position peaked at $2.67M in Q2 2024. 3,093 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • STF Management held 2,831 shares of Amgen worth $927K as of Q4 2025.
  • STF Management sold 5,198 Amgen shares in Q4 2025, an estimated $1.65M.
  • Amgen made up 0.87% of STF Management's portfolio in Q4 2025, its #26 holding.
  • STF Management first reported a position in Amgen in Q4 2022 and has held it in 13 quarters since.
  • STF Management's Amgen position peaked at $2.67M in Q2 2024.
  • 3,093 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on STF Management's 13F filing for Q4 2025, filed 5 Feb 2026.